AVTX Fundamental Analysis - AVANTIUM

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to AVTX. AVTX was compared to 34 industry peers in the Professional Services industry. AVTX may be in some trouble as it scores bad on both profitability and health. AVTX is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

AVTX had negative earnings in the past year.

AVTX had a negative operating cash flow in the past year.

AVTX had negative earnings in each of the past 5 years.

In the past 5 years AVTX always reported negative operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -8.13%, AVTX is doing worse than 87.50% of the companies in the same industry.

Looking at the Return On Equity, with a value of -28.68%, AVTX is doing worse than 87.50% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-8.13%
ROE	-28.68%
ROIC	N/A

ROA(3y)-13.38%

ROA(5y)-20.84%

ROE(3y)-43.19%

ROE(5y)-45.55%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With a decent Gross Margin value of 80.43%, AVTX is doing good in the industry, outperforming 75.00% of the companies in the same industry.

In the last couple of years the Gross Margin of AVTX has remained more or less at the same level.

AVTX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	80.43%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.37%

GM growth 5Y-1.4%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

AVTX does not have a ROIC to compare to the WACC, probably because it is not profitable.

AVTX has more shares outstanding than it did 1 year ago.

Compared to 5 years ago, AVTX has more shares outstanding

AVTX has a worse debt/assets ratio than last year.

2.2 Solvency

AVTX has an Altman-Z score of -1.72. This is a bad value and indicates that AVTX is not financially healthy and even has some risk of bankruptcy.

AVTX has a worse Altman-Z score (-1.72) than 93.75% of its industry peers.

AVTX has a Debt/Equity ratio of 0.54. This is a neutral value indicating AVTX is somewhat dependend on debt financing.

AVTX has a Debt to Equity ratio (0.54) which is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0.54
Debt/FCF	N/A
Altman-Z	-1.72

ROIC/WACCN/A

WACC7.08%

2.3 Liquidity

AVTX has a Current Ratio of 0.19. This is a bad value and indicates that AVTX is not financially healthy enough and could expect problems in meeting its short term obligations.

AVTX has a worse Current ratio (0.19) than 93.75% of its industry peers.

AVTX has a Quick Ratio of 0.19. This is a bad value and indicates that AVTX is not financially healthy enough and could expect problems in meeting its short term obligations.

AVTX has a worse Quick ratio (0.18) than 93.75% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.19
Quick Ratio	0.18

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

AVTX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 29.28%, which is quite impressive.

Looking at the last year, AVTX shows a very negative growth in Revenue. The Revenue has decreased by -12.31% in the last year.

AVTX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.76% yearly.

EPS 1Y (TTM)29.28%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%36.61%

Revenue 1Y (TTM)-12.31%

Revenue growth 3Y24.44%

Revenue growth 5Y8.76%

Sales Q2Q%-25.36%

3.2 Future

Based on estimates for the next years, AVTX will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.55% on average per year.

The Revenue is expected to grow by 54.51% on average over the next years. This is a very strong growth

EPS Next Y-9.56%

EPS Next 2Y21.89%

EPS Next 3Y20.73%

EPS Next 5Y9.55%

Revenue Next Year12.37%

Revenue Next 2Y47.56%

Revenue Next 3Y47.37%

Revenue Next 5Y54.51%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

AVTX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year AVTX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

AVTX's earnings are expected to grow with 20.73% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y21.89%

EPS Next 3Y20.73%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for AVTX!.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

AVANTIUM

AMS:AVTX (12/12/2025, 7:00:00 PM)

6.574

+0.02 (+0.34%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCommercial & Professional Services

GICS IndustryProfessional Services

Earnings (Last)08-13 2025-08-13

Earnings (Next)03-18 2026-03-18/amc

Inst Owners2.87%

Inst Owner ChangeN/A

Ins Owners1.85%

Ins Owner ChangeN/A

Market Cap165.66M

Revenue(TTM)18.76M

Net Income(TTM)-24.38M

Analysts80

Price Target26.23 (299%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)26.71%

PT rev (3m)5.87%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)3.72%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)-7.33%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	8.83
P/FCF	N/A
P/OCF	N/A
P/B	1.95
P/tB	2.02
EV/EBITDA	N/A

EPS(TTM)-1.86

EYN/A

EPS(NY)-1.84

Fwd EYN/A

FCF(TTM)-2.62

FCFYN/A

OCF(TTM)-1.07

OCFYN/A

SpS0.74

BVpS3.37

TBVpS3.25

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-8.13%
ROE	-28.68%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	80.43%
FCFM	N/A

ROA(3y)-13.38%

ROA(5y)-20.84%

ROE(3y)-43.19%

ROE(5y)-45.55%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.37%

GM growth 5Y-1.4%

F-Score2

Asset Turnover0.06

Health

		Industry Rank	Sector Rank
Debt/Equity	0.54
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	827.5%
Cap/Sales	207.85%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.19
Quick Ratio	0.18
Altman-Z	-1.72

F-Score2

WACC7.08%

ROIC/WACCN/A

Cap/Depr(3y)922.54%

Cap/Depr(5y)572.69%

Cap/Sales(3y)309.26%

Cap/Sales(5y)199.76%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)29.28%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%36.61%

EPS Next Y-9.56%

EPS Next 2Y21.89%

EPS Next 3Y20.73%

EPS Next 5Y9.55%

Revenue 1Y (TTM)-12.31%

Revenue growth 3Y24.44%

Revenue growth 5Y8.76%

Sales Q2Q%-25.36%

Revenue Next Year12.37%

Revenue Next 2Y47.56%

Revenue Next 3Y47.37%

Revenue Next 5Y54.51%

EBIT growth 1Y-7.82%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year2.23%

EBIT Next 3Y25.92%

EBIT Next 5Y18.19%

FCF growth 1Y3.93%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-170.49%

OCF growth 3YN/A

OCF growth 5YN/A

AVANTIUM / AVTX.AS FAQ

Can you provide the ChartMill fundamental rating for AVANTIUM?

ChartMill assigns a fundamental rating of 2 / 10 to AVTX.AS.

Can you provide the valuation status for AVANTIUM?

ChartMill assigns a valuation rating of 1 / 10 to AVANTIUM (AVTX.AS). This can be considered as Overvalued.

How profitable is AVANTIUM (AVTX.AS) stock?

AVANTIUM (AVTX.AS) has a profitability rating of 1 / 10.

What is the earnings growth outlook for AVANTIUM?

The Earnings per Share (EPS) of AVANTIUM (AVTX.AS) is expected to decline by -9.56% in the next year.

AVANTIUM (AVTX.AS) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

AVANTIUM / AVTX.AS FAQ

Can you provide the ChartMill fundamental rating for AVANTIUM?

Can you provide the valuation status for AVANTIUM?

How profitable is AVANTIUM (AVTX.AS) stock?

What is the earnings growth outlook for AVANTIUM?